Predicting long term lung health outcomes in young adults born very preterm (WALHIP 19 year old follow-up)
This study will conduct a detailed lung health assessment in a follow-up of a group of preterm individuals at 19 years of age.
LIFECYCLE - Early Life Stressors and LifeCycle Health
LIFECYCLE is a significant and visionary project to establish an integrated set of long-term world-wide cohorts and clinical trials, which can be investigated and compared across the full life of cohort participants.
Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis
Advances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.